| Literature DB >> 31656163 |
R Ryan Field1, Tuan Mai2, Samouel Hanna3, Brian Harrington2, Michael-David Calderon2, Joseph Rinehart2.
Abstract
BACKGROUND: Goal Directed Fluid Therapy (GDFT) represents an objective fluid replacement algorithm. The effect of provider variability remains a confounder. Overhydration worsens perioperative morbidity and mortality; therefore, the impact of the calculated NPO deficit prior to the operating room may reach harm.Entities:
Keywords: Fluid Management; Goal Directed Fluid Management; Goal Directed Fluid Therapy; NPO
Mesh:
Substances:
Year: 2019 PMID: 31656163 PMCID: PMC6815464 DOI: 10.1186/s12871-019-0864-x
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.217
Fig. 1Goal-directed fluid therapy protocol in use at UCI Medical Center during the study period. CI – Cardiac index. IBW – ideal body weight. SV – stroke volume. SVV – stroke volume variation
Fig. 2Patient Selection and Group Allocation. GDFT – Goal Directed Fluid Therapy; CHF – congestive heart failure; ESRD – end-stage renal disease; EBL – estimated blood loss
Demographic and Baseline Data in Both Groups
| Variable | AM ( | PM ( | |
|---|---|---|---|
| Age (years) | 60 ± 14 | 60 ± 17 | 0.9 |
| Gender | |||
| Male (%) | 166 (47%) | 53 (45%) | 0.75 |
| Female (%) | 187 (53%) | 65 (55%) | |
| Height (cm) | 169 ± 11 | 168 ± 11 | 0.38 |
| Weight (kg) | 78 ± 18 | 77 ± 21 | 0.74 |
| BMI (kg/m^2) | 27.1 ± 5.5 | 27 ± 6 | |
| ASA Class | |||
| I | 3 (0.9%) | 1 (0.9%) | 0.19 |
| II | 63 (18%) | 27 (23%) | |
| III | 249 (71%) | 76 (64%) | |
| IV | 38 (11%) | 15 (12%) | |
| Procedure | |||
| Laparoscopic | 131 (37%) | 27 (23%) |
|
| Open | 222 (63%) | 91 (77%) | |
| Epidural | 105 (30%) | 14 (12%) |
|
| Arterial Line | 271 (77%) | 55 (47%) |
|
| NPO time (hours) | 10.0 ± 2.5 | 12.5 ± 3.1 |
|
| Duration (hours) | 6.2 ± 2.7 | 4.1 ± 1.9 |
|
| EBL (milliliters) | 129 ± 135 | 107 ± 128 | 0.12 |
Two-sample t-test for continuous variables and Pearson's chi-squared test for binary/categorical variables. ASA American Society of Anesthesiologists, BMI Body Mass Index, NPO nil per os. P-values bolded of variables with significant difference between the AM vs PM groups
GDFT Monitoring Modality
| GDFT Monitoring Modality | Percent Utilization (%) |
|---|---|
| Esophageal Doppler | 4 |
| Plethysmograph PVI | 30 |
| Arterial Line PPV | 41 |
| Non-invasive Continuous Finger Cuff | 25 |
Administered Fluid and Net Fluid Balances between groups
| Total Expressed As | Crystalloid to Colloid Calculation | Volume expressed as | AM | PM | |
|---|---|---|---|---|---|
| Administered Volume | 1:1 | Total ml | 1970 ± 1220 | 1300 ± 850 |
|
| ml/hr | 340 ± 180 | 300 ± 160 |
| ||
| ml/kg/hr | 4.5 ± 2.5 | 4.0 ± 2.3 | 0.07 | ||
| 1:3 | Total ml | 1000 ± 690 | 640 ± 490 |
| |
| ml/hr | 164 ± 91 | 145 ± 92 | 0.07 | ||
| ml/kg/hr | 2.2 ± 1.3 | 2.0 ± 1.3 | 0.08 | ||
| Net Fluid Balance (volume) | 1:1 | Total ml | 1230 ± 1120 | 800 ± 810 |
|
| ml/hr | 220 ± 180 | 190 ± 170 | 0.16 | ||
| ml/kg/hr | 2.9 ± 2.5 | 2.5 ± 2.3 | 0.17 | ||
| 1:3 | Total ml | 270 ± 660 | 140 ± 500 |
| |
| ml/hr | 46 ± 103 | 36 ± 108 | 0.42 | ||
| ml/kg/hr | 0.6 ± 1.4 | 0.4 ± 1.4 | 0.35 |
Bold data denotes P-values less than 0.05
Linear Model Results with AM vs PM Start Time
| Variable | ||
|---|---|---|
| 1:1 Crystalloid:Colloid | 0.33:1 Crystalloid:Colloid | |
| Intercept | 0.785 | 0.360 |
| Group (AM vs. PM) | 0.640 | 0.187 |
| History of Hypertension | 0.380 | 0.209 |
| Gender | 0.476 | 0.081 |
| ASA | 0.018 | 0.002 |
| Epidural Placed | 0.002 | 0.001 |
| Arterial Line Used | 0.586 | 0.861 |
| Laparoscopic | 0.215 | 0.160 |
| Urine Output | 0.022 | 0.004 |
| Estimated Blood Loss | 0.000 | 0.000 |
| Patient Weight | 0.000 | 0.009 |
| Patient Age | 0.004 | 0.016 |
| Sugical Duration | 0.001 | 0.000 |
| Median MAP | 0.571 | 0.242 |
| Median HR | 0.090 | 0.108 |
Linear Model Results with NPO Time
| Variable | p-value in general linear model | |
|---|---|---|
| 1:1 Crystalloid:Colloid | 0.33:1 Crystalloid:Colloid | |
| Intercept | 0.294 | 0.170 |
| NPO time (hours) | 0.382 | 0.971 |
| History of Hypertension | 0.660 | 0.516 |
| Gender | 0.675 | 0.450 |
| ASA | 0.004 | 0.010 |
| Laparoscopic | 0.001 | 0.001 |
| Epidural Placed | 0.001 | 0.000 |
| Arterial Line Used | 0.582 | 0.075 |
| Urine Output | 0.002 | 0.000 |
| Estimated Blood Loss | 0.001 | 0.000 |
| Patient Weight | 0.001 | 0.016 |
| Patient Age | 0.082 | 0.044 |
| Sugical Duration | 0.000 | 0.000 |
| Median MAP | 0.662 | 0.185 |
| Median HR | 0.006 | 0.011 |
Fig. 3NPO Time Compared to Fluid Requirements by Goal-Directed Fluid Therapy. Regression lines for twelve different approaches to fluid-administration estimation. Each row represents a different calculation of amount administered: top row – total ml; middle row – ml/hour; bottom row – ml/kg/hr. The first column shows treatment of crystalloid to colloid on a 1:1 basis. The second column shows treatment of crystalloid to colloid on a 3:1 basis. The third and fourth column are again 1:1 and 3:1 treatment, but instead of total amount administered look instead at fluid balance (amount administered minus urine output and blood loss). None of the regressions indicate a significant relationship between longer NPO time and higher fluid requirements by GDFT protocol